| |
Pfizer Alzheimer's Disease Drug Fails In Study Pfizer Alzheimer's Disease Drug Fails In StudyA promising experimental Alzheimer's disease drug Pfizer Inc. and a partner are developing worked no better than a placebo in a late-stage study, an unexpected disappointment after the potential blockbuster stopped symptoms from worsening for a year in a prior test. More Recent Articles |
Click here to safely unsubscribe now from "KCCI.com - Health News" or change your subscription or subscribe
| Your requested content delivery powered by FeedBlitz, LLC, 9 Thoreau Way, Sudbury, MA 01776, USA. +1.978.776.9498 |
0 comments:
Post a Comment